Clinical trialObsCompleted
Circulating Tumor Cells in Operative Blood
Circulating Tumor Cells Shed in Operative Blood During Pancreatectomy for Pancreatic Cancer is Responsible for Peritoneal Recurrence
- Outcome
- Finished, no results posted
- Phase
- Obs
- Status
- Completed
- Study type
- Observational
- Start
- February 2015
- Expected end
- February 2016
- Enrollment
- 3 participants
- Sites
- 1
- Primary outcomes
- Percentage of patients with isolated circulating tumor cells; Percentage of patients with successful in vivo animal engraftment of isolated circulating tumor cells
- Sponsor
- Other
- Results posted
- No
- Last update
- 23 February 2016
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try